Republican leaders on the House Energy & Commerce Committee are calling for FDA to provide them with more information about ongoing drug shortages, including how the agency is working to mitigate shortages using the information that drug makers are supposed to report about manufacturing and supply. In addition to asking for responses to written questions, the lawmakers also want FDA to brief majority E&C staff on shortage issues. FDA has until April 10 to respond to the letter. The FDA...